Salvo Health
PrivateLast Round
Series A
Jan 15, 2026
Total Funding Raised
$28.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Salvo Health operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in January 2026.
Salvo Health is a digital health company that operates a virtual clinic platform to provide specialized, continuous care for patients with chronic gastrointestinal and metabolic conditions.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Vertical SaaS
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Salvo Health Comparables
Compare Salvo Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ayble Health | 84% | |
| SonarMD | 81% | |
| Oshi Health | 81% |
For institutional investors. Book with your work email.
Salvo Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 15, 2026 | ||||
| Convertible Debt | Jun 5, 2025 | ||||
| Seed | Feb 28, 2024 | ||||
| Seed | Aug 9, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Salvo Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Torch Capital | Convertible Debt, Series A, Seed |
| Threshold Ventures | Convertible Debt, Seed, Series A |
| Human Ventures | Series A, Convertible Debt, Seed |
| Owl Capital | Convertible Debt, Series A |
| Contour Venture Partners | Series A |
| Blue Owl Capital | Series A |
| The Artemis Fund | Convertible Debt, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2026
Grew 23% QoQ, from 61 to 75 employees.
- Jun 2, 2026
Revenue is up 8x since December 2024.
For institutional investors. Book with your work email.
Salvo Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Salvo Health's valuation, stock price, and market status.
Is Salvo Health a public or private company?
Salvo Health is a private company.
What is the current stock price of Salvo Health?
Salvo Health is a private company, so its shares have no public market price. Caplight tracks Salvo Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Salvo Health worth (valuation)?
Valuation information for Salvo Health is not publicly available.
Can I buy Salvo Health stock?
Salvo Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Salvo Health's last funding round?
Salvo Health's most recent funding round was Series A on January 15, 2026.
Who are the main investors in Salvo Health?
Key investors in Salvo Health include Threshold Ventures, Human Ventures, ManchesterStory Group, City Light Capital.
Will Salvo Health IPO soon?
No public IPO plans have been announced for Salvo Health.
How can I track Salvo Health secondary market activity?
Caplight tracks bids, offers, and trades in Salvo Health's shares on secondary markets.